Stocktoria
Janux Therapeutics, Inc. JANX
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-06-11
Janux Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 2,344,007 | $98.2M | 3.78% |
| Point72 Asset Management, L.P. | 1,156,140 | $16.1M | 1.87% |
| CITADEL ADVISORS LLC | 444,577 | $6.2M | 0.72% |
| MILLENNIUM MANAGEMENT LLC | 386,810 | $5.4M | 0.62% |
| TWO SIGMA INVESTMENTS, LP | 116,099 | $1.6M | 0.19% |
| D. E. Shaw & Co., Inc. | 98,395 | $1.4M | 0.16% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.